Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 155.17 USD -0.21% Market Closed
Market Cap: 373.6B USD
Have any thoughts about
Johnson & Johnson?
Write Note

Relative Value

The Relative Value of one JNJ stock under the Base Case scenario is 176.39 USD. Compared to the current market price of 155.17 USD, Johnson & Johnson is Undervalued by 12%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

JNJ Relative Value
Base Case
176.39 USD
Undervaluation 12%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
71
vs Industry
30
Median 3Y
4.8
Median 5Y
4.5
Industry
2.5
Forward
4.2
vs History
20
vs Industry
37
Median 3Y
22
Median 5Y
22
Industry
21.9
Forward
15.4
vs History
79
vs Industry
26
Median 3Y
17.4
Median 5Y
16.3
Industry
16.5
vs History
90
vs Industry
11
Median 3Y
19.6
Median 5Y
17.4
Industry
23.6
vs History
73
vs Industry
14
Median 3Y
5.5
Median 5Y
5.6
Industry
2.1
vs History
61
vs Industry
27
Median 3Y
4.9
Median 5Y
4.6
Industry
2.6
Forward
4.3
vs History
71
vs Industry
33
Median 3Y
7.1
Median 5Y
6.7
Industry
5.2
vs History
76
vs Industry
31
Median 3Y
13.1
Median 5Y
13.5
Industry
13.3
Forward
12.4
vs History
77
vs Industry
28
Median 3Y
17
Median 5Y
18.2
Industry
16.6
Forward
13.8
vs History
74
vs Industry
26
Median 3Y
17.4
Median 5Y
16.6
Industry
15.6
vs History
73
vs Industry
20
Median 3Y
21.3
Median 5Y
19.6
Industry
19.1
vs History
82
vs Industry
28
Median 3Y
2.8
Median 5Y
2.8
Industry
1.9

Multiples Across Competitors

JNJ Competitors Multiples
Johnson & Johnson Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
US
Pfizer Inc
NYSE:PFE
145.4B USD 2.4 34.2 10.3 15.5
P/E Multiple
Earnings Growth
US
Johnson & Johnson
NYSE:JNJ
Average P/E: 32.6
25.4
-22%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A
US
Pfizer Inc
NYSE:PFE
34.2
733%

See Also

Discover More
Back to Top